Orthocell Limited

ASX:OCC Stock Report

Market Cap: AU$230.6m

Orthocell Future Growth

Future criteria checks 2/6

Orthocell is forecast to grow earnings and revenue by 53.6% and 62.6% per annum respectively. EPS is expected to grow by 79.9% per annum. Return on equity is forecast to be -7.9% in 3 years.

Key information

53.6%

Earnings growth rate

79.93%

EPS growth rate

Biotechs earnings growth29.8%
Revenue growth rate62.6%
Future return on equity-7.86%
Analyst coverage

Low

Last updated20 Apr 2026

Recent future growth updates

Recent updates

We're Hopeful That Orthocell (ASX:OCC) Will Use Its Cash Wisely

Apr 04
We're Hopeful That Orthocell (ASX:OCC) Will Use Its Cash Wisely

Companies Like Orthocell (ASX:OCC) Are In A Position To Invest In Growth

Sep 09
Companies Like Orthocell (ASX:OCC) Are In A Position To Invest In Growth

It's Probably Less Likely That Orthocell Limited's (ASX:OCC) CEO Will See A Huge Pay Rise This Year

Oct 25
It's Probably Less Likely That Orthocell Limited's (ASX:OCC) CEO Will See A Huge Pay Rise This Year

We Think Orthocell (ASX:OCC) Can Afford To Drive Business Growth

Nov 16
We Think Orthocell (ASX:OCC) Can Afford To Drive Business Growth

We're Not Very Worried About Orthocell's (ASX:OCC) Cash Burn Rate

Jul 29
We're Not Very Worried About Orthocell's (ASX:OCC) Cash Burn Rate

Orthocell (ASX:OCC) Is In A Good Position To Deliver On Growth Plans

Mar 23
Orthocell (ASX:OCC) Is In A Good Position To Deliver On Growth Plans

We're Not Worried About Orthocell's (ASX:OCC) Cash Burn

Dec 08
We're Not Worried About Orthocell's (ASX:OCC) Cash Burn

Here's Why We're Not At All Concerned With Orthocell's (ASX:OCC) Cash Burn Situation

May 31
Here's Why We're Not At All Concerned With Orthocell's (ASX:OCC) Cash Burn Situation

Companies Like Orthocell (ASX:OCC) Are In A Position To Invest In Growth

Feb 15
Companies Like Orthocell (ASX:OCC) Are In A Position To Invest In Growth

How Does Orthocell's (ASX:OCC) CEO Salary Compare to Peers?

Dec 24
How Does Orthocell's (ASX:OCC) CEO Salary Compare to Peers?

Earnings and Revenue Growth Forecasts

ASX:OCC - Analysts future estimates and past financials data (AUD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/202845-1-11-32
6/30/202724-8-13-102
6/30/202613-12-13-132
12/31/20259-12-12-12N/A
9/30/20258-11-11-10N/A
6/30/20258-9-9-9N/A
3/31/20258-6-9-8N/A
12/31/20248-3-8-7N/A
9/30/20246-5-8-7N/A
6/30/20245-7-7-7N/A
3/31/20245-7-7-7N/A
12/31/20235-7-7-7N/A
9/30/20235-734N/A
6/30/20234-61415N/A
3/31/20233-71414N/A
12/31/20222-91314N/A
9/30/20222-934N/A
6/30/20222-9-7-6N/A
3/31/20221-9-6-6N/A
12/31/20211-9-6-6N/A
9/30/20211-9-5-5N/A
6/30/20211-9-5-5N/A
3/31/20211-9-4-4N/A
12/31/20201-8-4-4N/A
9/30/20201-7-5-5N/A
6/30/20201-6-5-5N/A
3/31/20201-6-7-6N/A
12/31/20191-7-8-8N/A
9/30/20191-6N/A-6N/A
6/30/20191-6N/A-4N/A
3/31/20191-6N/A-4N/A
12/31/20181-6N/A-4N/A
9/30/20181-6N/A-4N/A
6/30/20181-6N/A-5N/A
3/31/20181-4N/A-3N/A
12/31/20171-2N/A-2N/A
9/30/20171-3N/A-3N/A
6/30/20171-4N/A-4N/A
3/31/20171-4N/A-4N/A
12/31/20161-4N/A-4N/A
9/30/20161-4N/A-4N/A
6/30/20161-4N/A-3N/A
3/31/20161-4N/A-3N/A
12/31/20151-3N/A-3N/A
9/30/20151-4N/A-3N/A
6/30/20151-4N/A-3N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: OCC is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: OCC is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: OCC is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: OCC's revenue (62.6% per year) is forecast to grow faster than the Australian market (6.4% per year).

High Growth Revenue: OCC's revenue (62.6% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: OCC is forecast to be unprofitable in 3 years.

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/04/24 08:41
End of Day Share Price 2026/04/24 00:00
Earnings2025/12/31
Annual Earnings2025/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Orthocell Limited is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Brenton AndersonBell Potter
Shane StoreyCanaccord Genuity